Ustekinumab (Stelara): Mechanism, Clinical Evidence & Biosimilar Landscape 2025May 26, 2026 Notably, ustekinumab (brand name Stelara), developed by Janssen Biotech (Johnson & Johnson), stands as one…
Qilu Pharmaceutical Co., Ltd.: Pipeline, Biosimilars, and Innovative Drug StrategyMay 25, 2026 Notably, This competitive landscape analysis was generated using AI-powered research workflows in Eureka LS, which…
